Our professionals

Imagen del Dr. Javier Rodríguez Rodríguez, especialista en Oncología Médica de la Clínica Universidad de Navarra. El Dr. Rodríguez se dedica al tratamiento y la investigación de tumores gastrointestinales (esofagogástricos y colorrectales)

Dr. Javier Rodríguez

Co-Director of the Department of Medical Oncology. Specialist in Medical Oncology.
Exclusive focus on the treatment and research of gastrointestinal tumors (esophagogastric and colorectal)

Works at: Navarre headquarters Madrid headquarters
Make an appointment
Be part of: Clínica Universidad de Navarra Cancer Center Clínica Universidad de Navarra
INDEX H 28

Professional career

Medical degree from the University of Navarra (1997).

Specialist in Medical Oncology at Clínica Universidad de Navarra.

PhD in Medicine from the University of Navarra (2013).

Specialist in the gastrointestinal and hepatobiliary tumor units within the Department of Medical Oncology at Clínica Universidad de Navarra.

Since 2022, Co-Director of the Department of Medical Oncology at Clínica Universidad de Navarra.

Member of the Board of Directors of the CIMA Solid Tumors Program since 2022

Member of the Executive Committee of the Cancer Center of the University of Navarra (CCUN) since 2022

RESEARCH AREAS

  • He has participated in 15 competitively funded research projects, serving as principal investigator in three of them.
  • Supervisor of more than 15 final degree projects in the Faculty of Medicine.
  • Co-supervisor of 5 doctoral theses.
  • Principal investigator in more than 25 clinical trials conducted at Clínica Universidad de Navarra.
  • He has 4 six-year research terms (sexenios) recognized by the National Commission for the Evaluation of Research Activity (CNEAI)
  • Principal investigator of the Colorectal Cancer Group at Idisna (Navarra Health Research Institute)

AREAS OF INTEREST

  • Specialist in the multidisciplinary and comprehensive treatment of patients with esophageal cancer and gastric cancer, with more than 20 years of clinical experience.
  • Specialist in the multidisciplinary and comprehensive treatment of patients with colorectal cancer, with more than 20 years of clinical experience.

Activity

In teaching

  • Adjunct Professor at the UNAV Faculty of Medicine since 2018.
  • Course lead for the subject Clinical Cases in Oncology in the Faculty of Medicine, worth 3 ECTS.

In research

  • Author of more than 75 articles in indexed journals, 42 in the first quartile and more than 15 as first/lead author.
Imagen de un icono azul con un documento certificado.

Scientific organizations

  • Young Investigator Award. Blood Club. Central Society of Clinical Investigation. Chicago 1996.
  • Award to the Best Project of Basic Applied or Clinical Research in Breast Cancer. Novartis: Effects of inhibition of tyrosine kinase activity of the epidermal growth factor (EGF) family receptors on the regulation of breast cancer cell proliferation and apoptosis (2001).
  • Rafael Hervada Award for Biomedical Research: Myocardial regeneration with autologous myoblasts: experimental and clinical study. Rafael Hervada Hospital. December 2005.
  • Accesit to the Bayer-Schering-Pharma Award 2007 in Research on Lymphoproliferative Syndromes: Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia. XLIX AEHH National Meeting and XXIII SETH National Congress. Pamplona, October 2007.
  • FEHH-ASTRA ZENECA Award 2007. Epigenetic regulation of human cancer/testis antigen gene, HAGE, in chronic myeloid leukemia. XLIX AEHH National Meeting and XXIII SETH National Congress. Pamplona, October 2007.
  • BIAL Award 2009. The role of Epigenetics in the Prognosis and Pathogenesis of Acute Lymphoblastic Leukemia. Lisbon. May 2009.